The nurse in the oncology infusion center is caring for a 46-year-old male client.
1015:Return visit on day 6 of the second cycle of chemotherapy for non-Hodgkin lymphoma. Doxorubicin IV and vincristine IV were given on day 1 through a peripheral IV line in the left forearm. Filgrastim by subcutaneous injection once daily was started on day 2, 24 hours after the chemotherapy.
1025:Client reports: urine was red on the day after the chemotherapy and has been yellow since; scalp hair has been falling out since the first cycle; burning at the former IV site since day 2; sores in the mouth for 2 days, with pain that prevents eating; jaw pain for 2 days; numbness of the fingers of both hands; aching in the bones since the second filgrastim injection; pain in the left upper abdomen since last night; trouble breathing since this morning. Skin at the former IV site is red. Temperature 101.1° F (38.4° C).
The nurse has reviewed the Nurses' Notes from 1015 and 1025.
For each medication below, click to specify the findings that require notification of the primary health care provider (PHCP).
| Category | Potential Findings |
|---|---|
| Doxorubicin | |
| Vincristine | |
| Filgrastim |
Note: Each row must have at least 1 response option selected.